Partial microglial depletion through inhibition of colony-stimulating factor 1 receptor improves synaptic plasticity

Luisa Strackeljan1, David Baidoe-Ansah1, Hadi Mirzapourdelavar1

  • 1Molecular Neuroplasticity, German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.

Experimental Neurology
|February 16, 2025
PubMed

Insights

Partial reduction of microglia using PLX3397 (CSF1R inhibitor) in aged mice improved cognitive functions and synaptic plasticity without complete depletion, offering a safer strategy for brain health.

Area of Science:

  • Neuroscience
  • Immunology
  • Aging Research

Background:

  • Microglia depletion enhances cognitive function in aged mice but carries infection risks.
  • Colony-stimulating factor 1 receptor (CSF1R) inhibitors offer a potential method for partial microglia modulation.

Purpose of the Study:

  • To investigate if partial microglia reduction with PLX3397 (pexidartinib) can improve cognitive functions in aged mice.
  • To assess the impact of CSF1R inhibition on synaptic remodeling and plasticity in the aging hippocampus.

Main Methods:

  • Aged mice were treated with PLX3397 for 6 weeks to partially reduce microglia.
  • Microglia numbers, C1q expression, synaptic markers, and performance in cognitive tasks were analyzed.

Main Results:

  • PLX3397 treatment reduced microglia to young levels in the hippocampus and retrosplenial cortex.
  • Synaptic plasticity (long-term potentiation) and hippocampus-dependent memory were enhanced.
  • Changes in perineuronal net structure and increased expression of synaptic proteins (brevican, vGluT1, vGAT) were observed.

Conclusions:

  • Partial microglia reduction via CSF1R inhibition is a viable strategy to improve cognitive and synaptic functions in the aged brain.
  • This approach offers a safer alternative to complete microglia ablation for enhancing brain health in aging.

Related Concept Videos